BioSig Technologies, Inc.·4

Apr 8, 6:22 PM ET

Sieckhaus John 4

4 · BioSig Technologies, Inc. · Filed Apr 8, 2022

Insider Transaction Report

Form 4
Period: 2022-03-21
Sieckhaus John
Chief Operating Officer
Transactions
  • Award

    Common Stock

    2022-03-21+50,00050,000 total
  • Award

    Options

    2022-03-30+350,000350,000 total
    Exercise: $1.30Exp: 2032-03-30Common Stock (350,000 underlying)
Footnotes (2)
  • [F1]The reporting person received the shares as a one-time signing bonus upon the commencement of the reporting person's employment with the Company.
  • [F2]The shares underlying this stock option will vest over three years, with 1/3 vesting on the first anniversary of March 30, 2022 and 2/3 vesting in substantially equal quarterly installments thereafter, subject to the terms and conditions of the BioSig Technologies, Inc. 2012 Equity Incentive Plan.

Documents

1 file
  • 4
    ownership.xmlPrimary